National shortage of GLP-1 Receptor Agonist medications (semaglutide, dulaglutide and liraglutide)
There is currently a national shortage of GLP-1 Receptor Agonist medications (semaglutide, dulaglutide and liraglutide).
The supply issue is expected to continue until mid 2024. During this time patients may not be able to obtain their medication or may be issued a lower dose.
Our apologies. Patients who are prescribed these medications will receive direct correspondence with further details shortly.
Recent Posts
- Covid/Flu Vaccination Clinic – Saturday 7th October
- Adult Flu & Covid Vaccinations
- National shortage of GLP-1 Receptor Agonist medications (semaglutide, dulaglutide and liraglutide)
- ATT: Parents of Perins School students signed up to the Costa Rica school trip in October 2023.
- Covid-19 Spring Booster Programme
Popular Categories
- Surgery Updates (20)